Sunday, September 20, 2020

RB open Hull innovation centre as part of £200m investment

RB has today (3 Dec) opened its state-of-the-art Science and Innovation Centre (S&I Centre) in Hull as part of an ongoing £200 million investment programme in the city.

Alongside the new centre, RB is committing £95 million to significantly upgrade the manufacturing facilities on the Hull site which employs 1,400.

One of six major RB R&D facilities worldwide, the new UK S&I Centre will be the global technical innovation hub for household name consumer health products such as Nurofen and Strepsils.

The decision to locate the new Centre in the UK at the Hull site followed a comprehensive review which considered other centres across the globe.

“Despite the current macro-economic uncertainty in the UK, it is our firm belief that our new centre will help the country further develop its scientific talent and R&D credentials,” said RB CEO Laxman Narasimhan.

Launching its new report on innovation at RB’s S&I Centre in Hull today, Carolyn Fairbairn, Director-General of the CBI, said: “RB’s decision to build this centre in the Humber region is testament to how innovative R&D can thrive in the regions.

“However, despite numerous success stories such as RB, there remains a clear innovation investment imbalance between London and the South East and the rest of the UK.

“As we look beyond Brexit, the challenge for government and business is to create the best conditions for innovation to prosper in every region of the UK.”

As well as today’s significant site investment, RB is partnering with Hull York Medical School and the University of Hull to offer a brand-new MSc in Pharmacology and Drug Development.

The innovative MSc programme will provide students with critical insights into the entire development journey of a clinical drug from laboratory to consumers’ homes. Students will have unique access to RB’s state-of-the-art healthcare S&I Centre in Hull, and RB employees will deliver lectures and provide mentoring.

R&D teams for seven of RB’s biggest brands are based in Hull, while more than 300 million consumer units, comprising 1,000 different products, including Nurofen, Lemsip, Disprin, Bonjela, Dettol and E45, are manufactured at its city site each year. Over half of the company’s Hull-based employees work in science, and almost half of the global R&D workforce is based in Hull.

The S&I Centre is RB’s largest healthcare development centre in the world and the biggest single site investment in the company’s history.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.




Latest news

£1.1m engineering skills boost for Sheffield

In a national first, teenagers at UTC Sheffield will develop a new range of in demand high-level digital engineering skills following a £1.1 million...

Cable cleat manufacturer expands North Yorkshire headquarters

Cable cleat manufacturer, Ellis Patents, has invested £500,000 in a 25 per cent expansion of its North Yorkshire headquarters. The main element of the expansion...

Time Out: Spencer Coffin, director of Procure Direct

The weekend is just around the corner and that means another ‘Time Out’. This week Business Link talks to Spencer Coffin, director of Procure...

Yorkshire hydroelectric projects acquired

Two hydropower projects in Yorkshire have changed hands as part of a £4.74 million acquisition. The deal sees JLEN, a listed environmental infrastructure fund, swoop...

Leeds med-tech firm raises £2.2m via share placing

Surgical Innovations has successfully raised £2.2 million to reinflate working capital, invest in new product development and sustainability support initiatives. The AIM listed Leeds-based med-tech...

ITM Power part of major hydrogen partnership

Sheffield hydrogen specialist, ITM Power, is one third of a new partnership which aims to use the clean renewable fuel to help Scotland achieve...

Related news

£1.1m engineering skills boost for Sheffield

In a national first, teenagers at UTC Sheffield will develop a new range of in demand high-level digital engineering skills following a £1.1 million...

Cable cleat manufacturer expands North Yorkshire headquarters

Cable cleat manufacturer, Ellis Patents, has invested £500,000 in a 25 per cent expansion of its North Yorkshire headquarters. The main element of the expansion...

Time Out: Spencer Coffin, director of Procure Direct

The weekend is just around the corner and that means another ‘Time Out’. This week Business Link talks to Spencer Coffin, director of Procure...

Yorkshire hydroelectric projects acquired

Two hydropower projects in Yorkshire have changed hands as part of a £4.74 million acquisition. The deal sees JLEN, a listed environmental infrastructure fund, swoop...

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close